Fibrolamellar Hepatocellular Carcinoma: Causes & Symptoms

Fibrolamellar hepatocellular carcinoma is a rare type of liver cancer that typically affects young adults. This disease is different from other types of liver cancer and has its own unique characteristics. Understanding the specific features of fibrolamellar hepatocellular carcinoma can help patients and their families navigate the challenges associated with this diagnosis. While the causes of this cancer are not fully understood, researchers are actively studying potential risk factors. By raising awareness and promoting early detection, we can improve outcomes for individuals facing fibrolamellar hepatocellular carcinoma.

What Are the Symptoms of Fibrolamellar Hepatocellular Carcinoma?

Symptoms of fibrolamellar hepatocellular carcinoma may include abdominal pain, unexplained weight loss, jaundice (yellowing of the skin and eyes), fatigue, and a feeling of fullness in the upper abdomen. Some people with this rare type of liver cancer may also experience nausea, vomiting, and a palpable mass in the abdomen. Early detection and prompt medical attention are crucial for effective treatment.

Unexplained weight loss: If you are losing weight without trying, it could be a symptom of fibrolamellar hepatocellular carcinoma.
Abdominal pain or discomfort: Persistent pain or discomfort in your abdomen that doesn't go away should be checked by a doctor, as it could be a sign of this type of liver cancer.
Jaundice: If your skin or eyes appear yellow, it may be due to a build-up of bilirubin caused by fibrolamellar hepatocellular carcinoma.
Fatigue: Feeling extremely tired even after getting enough rest could be a symptom of this type of liver cancer.
Enlarged liver: If you notice your abdomen becoming swollen or feel a lump in your upper right abdomen, it may indicate an enlarged liver, which can be associated with fibrolamellar hepatocellular carcinoma.

Get a second opinion from trusted experts and makeconfident, informed decisions.

Get Second Opinion

Causes of Fibrolamellar Hepatocellular Carcinoma

The exact cause of fibrolamellar hepatocellular carcinoma remains unclear, but it is believed to be linked to a genetic mutation in the DNA of liver cells. This mutation typically occurs in young adults with no history of liver disease or risk factors, making it a rare form of liver cancer. Other factors such as environmental exposures and lifestyle choices may also play a role in the development of this condition.

Genetic mutations, particularly in the DNAJB1-PRKACA fusion gene, are a common cause of fibrolamellar hepatocellular carcinoma.
Exposure to environmental toxins and chemicals, such as aflatoxins and vinyl chloride, has been linked to the development of fibrolamellar hepatocellular carcinoma.
Chronic liver diseases, including hepatitis B and hepatitis C infections, can increase the risk of developing fibrolamellar hepatocellular carcinoma.
Certain metabolic disorders, such as Wilson's disease and hemochromatosis, are associated with an elevated risk of fibrolamellar hepatocellular carcinoma.
Inflammation and liver damage caused by conditions like non-alcoholic fatty liver disease (NAFLD) can also contribute to the risk of developing fibrolamellar hepatocellular carcinoma.

Types Of Fibrolamellar Hepatocellular Carcinoma

Fibrolamellar hepatocellular carcinoma has two main types: classic and non-classic. The classic type has distinct features like a central scar, while the non-classic type may not have these characteristics. Both types share common symptoms and treatment options, but the distinction helps doctors determine the specific characteristics of the tumor and tailor treatment accordingly.

Classic Fibrolamellar Hepatocellular Carcinoma: This type of FL-HCC is characterized by the presence of large polygonal cells with abundant eosinophilic granular cytoplasm and prominent nucleoli, surrounded by fibrous stroma.
Small Cell Variant of Fibrolamellar Hepatocellular Carcinoma: This subtype is characterized by small tumor cells with scant cytoplasm and hyperchromatic nuclei, often mimicking small cell carcinoma of the lung on histological examination.
Sclerosing Fibrolamellar Hepatocellular Carcinoma: This rare variant of FL-HCC is characterized by extensive stromal fibrosis and collagen deposition within the tumor, leading to a distinct morphological appearance that can complicate diagnosis.

Risk Factors

Risk factors for fibrolamellar hepatocellular carcinoma include being younger than 35 years old, having no underlying liver disease, and being female. Other potential risk factors include a history of hepatitis B or C infection, exposure to certain environmental toxins, and genetic mutations. It is important to be aware of these risk factors and discuss any concerns with a healthcare provider for early detection and management.

Having a genetic mutation in the DNAJB1-PRKACA fusion gene is a significant risk factor for developing fibrolamellar hepatocellular carcinoma.
Young adults and adolescents are at higher risk of developing fibrolamellar hepatocellular carcinoma compared to older adults.
Exposure to environmental toxins, such as aflatoxins produced by molds, can increase the risk of developing fibrolamellar hepatocellular carcinoma.
Individuals with a history of liver diseases, such as hepatitis B or C infection, have an elevated risk of developing fibrolamellar hepatocellular carcinoma.
Obesity and metabolic conditions, such as non-alcoholic fatty liver disease (NAFLD), are associated with an increased risk of developing fibrolamellar hepatocellular carcinoma due to their impact on liver health and function.

Your health is everything - prioritize your well-being today.

Schedule Your Appointment

Diagnosis of Fibrolamellar Hepatocellular Carcinoma

Blood tests, imaging studies like CT scans and MRIs, and a liver biopsy may be done to confirm the diagnosis. Doctors may also use specific biomarkers to aid in diagnosis. It's important to consult with a healthcare provider for proper evaluation and treatment.

Imaging studies such as ultrasound, CT scan, and MRI are commonly used to diagnose fibrolamellar hepatocellular carcinoma by visualizing the liver and detecting any abnormalities.
Blood tests that measure liver function and specific tumor markers like alpha-fetoprotein (AFP) can aid in the diagnosis of fibrolamellar hepatocellular carcinoma.
Biopsy, where a small sample of liver tissue is taken and examined under a microscope, is a definitive method to confirm the presence of fibrolamellar hepatocellular carcinoma.
Genetic testing may be performed to detect mutations associated with fibrolamellar hepatocellular carcinoma, such as DNAJB1-PRKACA fusion gene.
Positron emission tomography (PET) scans can be utilized to assess metabolic activity in liver tumors and help differentiate between benign and malignant lesions, aiding in the diagnosis of fibrolamellar hepatocellular carcinoma.

Treatment for Fibrolamellar Hepatocellular Carcinoma

Treatment options for fibrolamellar hepatocellular carcinoma may include surgery to remove the tumor, liver transplant, chemotherapy, and targeted therapy. Your healthcare team will develop a personalized treatment plan based on your specific situation. It is crucial to discuss all available options with your healthcare provider to determine the best course of action for managing your condition effectively.

Surgical resection is often the primary treatment for fibrolamellar hepatocellular carcinoma, involving the removal of the tumor and surrounding tissue to prevent its spread.
Liver transplantation may be considered for eligible patients with fibrolamellar hepatocellular carcinoma, particularly when the tumor is unresectable or when there is underlying liver disease.
Radiofrequency ablation, a minimally invasive procedure that uses heat to destroy cancer cells, can be used as a treatment option for smaller fibrolamellar hepatocellular carcinoma tumors.
Targeted therapies, such as sorafenib and lenvatinib, may be prescribed to inhibit specific pathways involved in the growth and spread of fibrolamellar hepatocellular carcinoma.

Find Our Specialists

Book Doctor Appointment

Name*

Mobile Number*

I agree to the Medicover Privacy Policy

International Patient Services

Still have questions? Speak with our experts now!

040-68334455

Frequently Asked Questions

What are the common signs of fibrolamellar hepatocellular carcinoma?

Common signs of fibrolamellar hepatocellular carcinoma include abdominal pain, weight loss, jaundice, and a palpable mass in the abdomen.

What are the recommended do's and don'ts for managing fibrolamellar hepatocellular carcinoma?

Do: Seek expert care, stay informed, follow treatment plan. Don't: Delay seeking medical help, ignore symptoms, self-medicate.

How can fibrolamellar hepatocellular carcinoma affect the body in the long term?

Fibrolamellar hepatocellular carcinoma can lead to liver failure, weight loss, jaundice, and other symptoms if left untreated.

How can fibrolamellar hepatocellular carcinoma be treated and controlled?

Surgery is the main treatment for fibrolamellar hepatocellular carcinoma. Other options include chemotherapy, radiation therapy, and targeted therapy. Regular monitoring is important after surgery to check for recurrence or metastasis.